ML SA1
CAS No. 332382-54-4
ML SA1 ( Mucolipin synthetic agonist 1 )
Catalog No. M24271 CAS No. 332382-54-4
ML-SA1 is a selective TRPML agonist, inhibits Dengue virus 2 (DENV2) and Zika virus (ZIKV) by promoting lysosomal acidification and protease activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
|
10MG | 67 | In Stock |
|
25MG | 139 | In Stock |
|
50MG | 230 | In Stock |
|
100MG | 346 | In Stock |
|
200MG | 520 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML SA1
-
NoteResearch use only, not for human use.
-
Brief DescriptionML-SA1 is a selective TRPML agonist, inhibits Dengue virus 2 (DENV2) and Zika virus (ZIKV) by promoting lysosomal acidification and protease activity.
-
DescriptionML-SA1 is a selective TRPML agonist, inhibits Dengue virus 2 (DENV2) and Zika virus (ZIKV) by promoting lysosomal acidification and protease activity. The IC50 value of ML-SA1 against DENV2 RNA and ZIKV RNA is 8.3 μM and 52.99 μM, respectively[1].
-
SynonymsMucolipin synthetic agonist 1
-
PathwayOthers
-
TargetOther Targets
-
RecptorTRPML
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number332382-54-4
-
Formula Weight362.4
-
Molecular FormulaC22H22N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:17 mg/mL (46.90 mM)
-
SMILESCC(CC1(C)C)c(cccc2)c2N1C(CN(C(c1c2cccc1)=O)C2=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xia Z, et al. ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity. Antiviral Res. 2020;182:104922.
molnova catalog
related products
-
TM6089
TM6089 is a unique Prolyl Hydroxylase inhibitor which stimulates HIF activity without iron chelation and induces angiogenesis and exerts organ protection against ischemia.
-
CNP-AFU
CNP-AFU is the substrate of alpha-L-fucosidase.
-
Dammarenediol II
Dammarenediol II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy.